FOLD - CIK 0001178879
AMICUS THERAPEUTICS, INC. (FOLD) reported net income of -$27.11M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$27.11M | +51.7% |
| FY 2024 | -$56.11M | +63.0% |
| FY 2023 | -$151.58M | +35.9% |
| FY 2022 | -$236.57M | +5.5% |
| FY 2021 | -$250.46M | +9.5% |
| FY 2020 | -$276.85M | +22.3% |
| FY 2019 | -$356.39M | -2.1% |
| FY 2018 | -$349.00M | -22.9% |
| FY 2017 |
AMICUS THERAPEUTICS, INC. (FOLD) reported net income of -$27.11M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, AMICUS THERAPEUTICS, INC.'s net income grew from -$44.41M to -$27.11M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$284.00M |
| -42.0% |
| FY 2016 | -$200.04M | -51.4% |
| FY 2015 | -$132.12M | -91.7% |
| FY 2014 | -$68.93M | -15.6% |
| FY 2013 | -$59.63M | -22.2% |
| FY 2012 | -$48.78M | -9.8% |
| FY 2011 | -$44.41M | - |